Of all variant classes, RET amplifications were the most commonly observed and mainly found in ER− and ERBB2− (ERBB2 wild-type/HER2-) breast cancers, followed by missense mutations and rearrangements. The gene discussed is ERBB2; the disease is breast carcinoma.